475
Views
58
CrossRef citations to date
0
Altmetric
Drug Evaluations

Darinaparsin: a novel organic arsenical with promising anticancer activity

, , &
Pages 1727-1734 | Published online: 23 Oct 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Christopher M. Cabello, Sarah D. Lamore, Warner B. Bair$suffix/text()$suffix/text(), Angela L. Davis, Sara M. Azimian & Georg T. Wondrak. (2011) DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma. Free Radical Research 45:3, pages 276-292.
Read now

Articles from other publishers (57)

Yuan-Yuan Guo, Jing-Yi Zhang, Jin-Feng Sun, Peng Nie & Hua Gao. (2023) Synthesis and application of small molecules approved for the treatment of lymphoma. European Journal of Medicinal Chemistry 261, pages 115835.
Crossref
Erika AraujoIan M. BellAlexander BurckleDennis C. KoesterJames R. ManningGeorgette Castanedo, Mingshuo Zeng, T. G. Murali DharNatalie Holmberg-Douglas, Eric R. Welin, J. Robert MerrittKevin M. PeeseJoanne J. Bronson. 2023. 2023 Medicinal Chemistry Reviews. 2023 Medicinal Chemistry Reviews 595 710 .
Won-Seog Kim, Noriko Fukuhara, Dok-Hyun Yoon, Kazuhito Yamamoto, Toshiki Uchida, Eiju Negoro, Koji Izutsu, Yasuhito Terui, Hideaki Nakajima, Kiyoshi Ando, Youko Suehiro, Hye Jin Kang, Po-Shen Ko, Fumiko Nagahama, Yusuke Sonehara, Hirokazu Nagai, Hwei-Fang Tien, Yok-Lam Kwong & Kensei Tobinai. (2023) Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study. Blood Advances 7:17, pages 4903-4912.
Crossref
Kozo YaoYusuke SoneharaFumiko Nagahama. (2023) Pharmacological profile and clinical study results of darinaparsin (DARVIAS<sup>®</sup> injection 135 ‍mg), an organic arsenic product, for relapsed or refractory peripheral t-cell lymphoma有機ヒ素製剤 ダリナパルシン(ダルビアス<sup>®</sup>点滴静注用135 ‍mg)の薬理学的特性と再発又は難治性の末梢性T細胞リンパ腫に対する臨床試験成績. Folia Pharmacologica Japonica 158:5, pages 408-418.
Crossref
Junjun Jing, Zhuoxuan Wu, Jiahe Wang, Guowen Luo, Hengyi Lin, Yi Fan & Chenchen Zhou. (2023) Hedgehog signaling in tissue homeostasis, cancers, and targeted therapies. Signal Transduction and Targeted Therapy 8:1.
Crossref
Ngozi P. Paul, Adriana E. Galván, Kunie Yoshinaga-Sakurai, Barry P. Rosen & Masafumi Yoshinaga. (2022) Arsenic in medicine: past, present and future. BioMetals 36:2, pages 283-301.
Crossref
Rajbinder K. Virk, Roobee Garla, Naveen Kaushal, Mohinder P. Bansal, Mohan L. Garg & Biraja P. Mohanty. (2023) The relevance of arsenic speciation analysis in health & medicine. Chemosphere 316, pages 137735.
Crossref
Bo Yuan, Hidetomo Kikuchi, Jingmei Li, Atsushi Kawabata, Kozo Yao, Norio Takagi & Mari Okazaki. (2023) Cytotoxic Effects of Darinaparsin, a Novel Organic Arsenical, against Human Leukemia Cells. International Journal of Molecular Sciences 24:3, pages 2282.
Crossref
Eiju NegoroTakahiro YamauchiNoriko FukuharaKazuhito YamamotoToshiki UchidaKoji IzutsuDai MaruyamaYasuhito TeruiHideaki NakajimaKiyoshi AndoYouko SuehiroIlseung ChoiNobuhiro KanemuraNobuhiko NakamuraGo YamamotoYoshinobu MaedaHirohiko ShibayamaFumiko NagahamaYusuke SoneharaHirokazu NagaiHwei-Fang TienYok-Lam KwongWon-Seog Kim & Kensei Tobinai. (2023) Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma. Journal of Clinical and Experimental Hematopathology 63:2, pages 108-120.
Crossref
Su-Zhen WuYu-Yan LanChiao-Yun ChuYi-Ping LeeHong-Yi ChangBu-Miin Huang. (2022) Sodium arsenite and dimethylarsenic acid induces apoptosis in OC3 oral cavity cancer cells. Molecular Medicine Reports 27:2.
Crossref
James E. Frampton. (2022) Darinaparsin: First Approval. Drugs 82:16, pages 1603-1609.
Crossref
Yi Ming Shao, Bold Sharavyn, Ping Huang, Hua Naranmandura & Qian Qian Wang. (2022) Development of Metal-Based Drugs and Application in Clinical Treatment. The Natural Products Journal 12:3.
Crossref
Meng Zhang, Lijuan Gao, Yiping Ye & Xiaoyu Li. (2021) Advances in glioma-associated oncogene (GLI) inhibitors for cancer therapy. Investigational New Drugs 40:2, pages 370-388.
Crossref
Su-Zhen WuYu-Yan LanChiao-Yun ChuYang-Kao WangYi-Ping LeeHong-Yi ChangBu-Miin Huang. (2022) Arsenic compounds induce apoptosis by activating the MAPK and caspase pathways in FaDu oral squamous carcinoma cells. International Journal of Oncology 60:2.
Crossref
Trinath Chowdhury, Gourisankar Roymahapatra & Santi M. Mandal. (2021) In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases. Infectious Disorders - Drug Targets 21:4, pages 608-618.
Crossref
Michinori Ogura, Won-Seog Kim, Toshiki Uchida, Naokuni Uike, Youko Suehiro, Kenichi Ishizawa, Hirokazu Nagai, Fumiko Nagahama, Yusuke Sonehara & Kensei Tobinai. (2021) Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea. Japanese Journal of Clinical Oncology 51:2, pages 218-227.
Crossref
Junmin Zhang, Dongzhu Duan, Zi‐Long Song, Tianyu Liu, Yanan Hou & Jianguo Fang. (2020) Small molecules regulating reactive oxygen species homeostasis for cancer therapy. Medicinal Research Reviews 41:1, pages 342-394.
Crossref
Jiayuan Mao, Qianlei Yang, Makoto Miyazawa, Motofumi Miura, Luna Wang, Haixuan Xia, Koichi Kato, Kenzo Yamanaka & Yan An. (2020) Possible differences in the mechanism of malignant transformation of HaCaT cells by arsenite and its dimethyl metabolites, particularly dimethylthioarsenics. Journal of Trace Elements in Medicine and Biology 61, pages 126544.
Crossref
Xiaohan Xu, Haibo Wang, Hongyan Li & Hongzhe Sun. (2020) Metalloproteomic Approaches for Matching Metals to Proteins: The Power of Inductively Coupled Plasma Mass Spectrometry (ICP-MS). Chemistry Letters 49:6, pages 697-704.
Crossref
Marta Ruiz-Ortega, Sandra Rayego-Mateos, Santiago Lamas, Alberto Ortiz & Raul R. Rodrigues-Diez. (2020) Targeting the progression of chronic kidney disease. Nature Reviews Nephrology 16:5, pages 269-288.
Crossref
Jamaluddin Mahar, Aamer Saeed, Gul-e-Saba Chaudhry, Madiha Irfan, Pervaiz Ali Channar, Muhammad Faisal & Fayaz Ali Larik. (2019) Synthesis, characterization and cytotoxic studies of novel 1,2,4-triazole-azomethine conjugates. Journal of the Iranian Chemical Society 17:4, pages 943-951.
Crossref
Xiaohan Xu, Haibo Wang, Hongyan Li, Xuqiao Hu, Yu Zhang, Xinyuan Guan, Patrick H. Toy & Hongzhe Sun. (2019) S -Dimethylarsino-glutathione (darinaparsin®) targets histone H3.3, leading to TRAIL-induced apoptosis in leukemia cells . Chemical Communications 55:87, pages 13120-13123.
Crossref
Yasuyo Shimoda, Koichi Kato, Satoru Asami, Masahiro Kurita, Hidetoshi Kurosawa, Masaharu Toriyama, Motofumi Miura, Akihisa Hata, Yoko Endo, Ginji Endo, Yan An & Kenzo Yamanaka. (2018) Differences in apoptotic signaling and toxicity between dimethylmonothioarsinic acid (DMMTAV) and its active metabolite, dimethylarsinous acid (DMAIII), in HepaRG cells: Possibility of apoptosis cascade based on diversity of active metabolites of DMMTAV. Journal of Trace Elements in Medicine and Biology 50, pages 188-197.
Crossref
Ying Zhou, Haibo Wang, Eric Tse, Hongyan Li & Hongzhe Sun. (2018) Cell Cycle-Dependent Uptake and Cytotoxicity of Arsenic-Based Drugs in Single Leukemia Cells. Analytical Chemistry 90:17, pages 10465-10471.
Crossref
Kaviyarasi Renu, Harishkumar Madhyastha, Radha Madhyastha, Masugi Maruyama, Sankarganesh Arunachlam & Abilash V.G.. (2018) Role of arsenic exposure in adipose tissue dysfunction and its possible implication in diabetes pathophysiology. Toxicology Letters 284, pages 86-95.
Crossref
Harishkumar Madhyastha, Radha Madhyastha, Yuichi Nakajima & Masugi Maruyama. (2017) Deciphering the molecular events during arsenic induced transcription signal cascade activation in cellular milieu. BioMetals 31:1, pages 7-15.
Crossref
Pingyu Zhang & Peter J. Sadler. (2017) Advances in the design of organometallic anticancer complexes. Journal of Organometallic Chemistry 839, pages 5-14.
Crossref
Islam Khairul, Qian Qian Wang, Yu Han Jiang, Chao Wang & Hua Naranmandura. (2017) Metabolism, toxicity and anticancer activities of arsenic compounds. Oncotarget 8:14, pages 23905-23926.
Crossref
Wei Qin, Yongjiang Zheng, Bin-Zhi Qian & Meng Zhao. (2017) Prostate Cancer Stem Cells and Nanotechnology: A Focus on Wnt Signaling. Frontiers in Pharmacology 8.
Crossref
Soumya Chatterjee, Sibnarayan Datta & Dharmendra K. Gupta. 2017. Arsenic Contamination in the Environment. Arsenic Contamination in the Environment 37 66 .
Rafael Kramann. (2016) Hedgehog Gli signalling in kidney fibrosis. Nephrology Dialysis Transplantation 31:12, pages 1989-1995.
Crossref
Barbara A. Roggenbeck, Mayukh Banerjee & Elaine M. Leslie. (2016) Cellular arsenic transport pathways in mammals. Journal of Environmental Sciences 49, pages 38-58.
Crossref
Koren K. Mann & Maryse Lemaire. 2015. Arsenic. Arsenic 315 345 .
Rafael Kramann, Susanne V. Fleig, Rebekka K. Schneider, Steven L. Fabian, Derek P. DiRocco, Omar Maarouf, Janewit Wongboonsin, Yoichiro Ikeda, Dirk Heckl, Steven L. Chang, Helmut G. Rennke, Sushrut S. Waikar & Benjamin D. Humphreys. (2015) Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis. Journal of Clinical Investigation 125:8, pages 2935-2951.
Crossref
Mingfu Yang, Yong Pan & Yue Zhou. (2015) Depletion of ALX1 causes inhibition of migration and induction of apoptosis in human osteosarcoma. Tumor Biology 36:8, pages 5965-5970.
Crossref
Yasuyo Shimoda, Hidetoshi Kurosawa, Koichi Kato, Yoko Endo, Kenzo Yamanaka & Ginji Endo. (2015) Proposal for novel metabolic pathway of highly toxic dimethylated arsenics accompanied by enzymatic sulfuration, desulfuration and oxidation. Journal of Trace Elements in Medicine and Biology 30, pages 129-136.
Crossref
Nitu Bansal, Nadine Johnson Farley, Lisa Wu, Jonathan Lewis, Hagop Youssoufian & Joseph R. Bertino. (2015) Darinaparsin Inhibits Prostate Tumor–Initiating Cells and Du145 Xenografts and Is an Inhibitor of Hedgehog Signaling. Molecular Cancer Therapeutics 14:1, pages 23-30.
Crossref
Beibei Chen, Qingqing Liu, Aleksandra Popowich, Shengwen Shen, Xiaowen Yan, Qi Zhang, Xing-Fang Li, Michael Weinfeld, William R. Cullen & X. Chris Le. (2015) Therapeutic and analytical applications of arsenic binding to proteins. Metallomics 7:1, pages 39-55.
Crossref
Khairul Islam, Qian Qian Wang & Hua Naranmandura. 2015. 77 107 .
Lingzhi Zhong, Yang Wang, Wenxue Li, Junlian Gu, Xiuying Li, Xiaotong Wang, Zhen Yue, Yan Mu, Jinping Bai, Ronggui Li & Haiying Zhang. (2014) Heme oxygenase-1 silencing increases the sensitivity of human osteosarcoma MG63 cells to arsenic trioxide. Molecular and Cellular Biochemistry 392:1-2, pages 135-144.
Crossref
Lucy Yehiayan, Szabina Stice, Guangliang Liu, Shannon Matulis, Lawrence H. Boise & Yong Cai. (2014) Dimethylarsinothioyl Glutathione as a Metabolite in Human Multiple Myeloma Cell Lines upon Exposure to Darinaparsin. Chemical Research in Toxicology 27:5, pages 754-764.
Crossref
Nicolas Garnier, Geneviève G. J. Redstone, Michael S. Dahabieh, Jessica N. Nichol, Sonia V. del Rincon, Yuxuan Gu, D. Scott Bohle, Yan Sun, Douglas S. Conklin, Koren K. Mann & Wilson H. MillerJr.Jr.. (2014) The Novel Arsenical Darinaparsin Is Transported by Cystine Importing Systems. Molecular Pharmacology 85:4, pages 576-585.
Crossref
N Garnier, L A Petruccelli, M F Molina, M Kourelis, S Kwan, Z Diaz, H M Schipper, A Gupta, S V del Rincon, K K Mann & W H Miller. (2013) The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells. Leukemia 27:11, pages 2220-2228.
Crossref
Balázs Németi & Zoltán Gregus. (2013) Reduction of Dimethylarsinic Acid to the Highly Toxic Dimethylarsinous Acid by Rats and Rat Liver Cytosol. Chemical Research in Toxicology 26:3, pages 432-443.
Crossref
Larissa Leffers, Marlies Unterberg, Marc Bartel, Cornelia Hoppe, Imke Pieper, Julia Stertmann, Franziska Ebert, Hans-Ulrich Humpf & Tanja Schwerdtle. (2013) In vitro toxicological characterisation of the S-containing arsenic metabolites thio-dimethylarsinic acid and dimethylarsinic glutathione. Toxicology 305, pages 109-119.
Crossref
D. Scott Bohle & Yuxuan Gu. (2013) Facile dimethylarsenic exchange and pyramidal inversion in its cysteine and glutathione adducts. Organic & Biomolecular Chemistry 11:16, pages 2578.
Crossref
Junqiang Tian, Hongjuan Zhao, Rosalie Nolley, Stephen W. Reese, Sarah R. Young, Xuejun Li, Donna M. Peehl & Susan J. Knox. (2012) Darinaparsin: Solid Tumor Hypoxic Cytotoxin and Radiosensitizer. Clinical Cancer Research 18:12, pages 3366-3376.
Crossref
Yang Wang, Yudan Wei, Haiying Zhang, Yanfen Shi, Yulin Li & Ronggui Li. (2011) Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase. Medical Oncology 29:2, pages 1328-1334.
Crossref
Jian-Xiang Liu, Guang-Biao Zhou, Sai-Juan Chen & Zhu Chen. (2012) Arsenic compounds: revived ancient remedies in the fight against human malignancies. Current Opinion in Chemical Biology 16:1-2, pages 92-98.
Crossref
Elaine M. Leslie. (2012) Arsenic–glutathione conjugate transport by the human multidrug resistance proteins (MRPs/ABCCs). Journal of Inorganic Biochemistry 108, pages 141-149.
Crossref
Peter J. Hosein, Michael D. Craig, Martin S. Tallman, Ralph V. Boccia, Brian L. Hamilton, Jonathan J. Lewis & Izidore S. Lossos. (2011) A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non‐Hodgkin's lymphoma. American Journal of Hematology 87:1, pages 111-114.
Crossref
Michael W. Carew, Hua Naranmandura, Caley B. Shukalek, X. Chris Le & Elaine M. Leslie. (2011) Monomethylarsenic Diglutathione Transport by the Human Multidrug Resistance Protein 1 (MRP1/ ABCC1 ) . Drug Metabolism and Disposition 39:12, pages 2298-2304.
Crossref
Ute JungwirthChristian R. KowolBernhard K. KepplerChristian G. HartingerWalter BergerPetra Heffeter. (2011) Anticancer Activity of Metal Complexes: Involvement of Redox Processes. Antioxidants & Redox Signaling 15:4, pages 1085-1127.
Crossref
Alberto J. Montero & Jacek Jassem. (2011) Cellular Redox Pathways as a Therapeutic Target in the Treatment of Cancer. Drugs 71:11, pages 1385-1396.
Crossref
Sai-Juan ChenGuang-Biao Zhou, Xiao-Wei ZhangJian-Hua MaoHugues de Thé & Zhu Chen. (2011) From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia. Blood 117:24, pages 6425-6437.
Crossref
Vandana Prajapati, Raosaheb K Kale & Rana P Singh. (2011) Arsenic and its combinations in cancer therapeutics. Therapeutic Delivery 2:6, pages 793-806.
Crossref
Gijsbert B. van der Voet. 2011. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 447 463 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.